-
These Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected Earnings
04 Aug 2025 18:29 GMT
… to their price targets on Regeneron Pharmaceuticals following earnings announcement.
Trending … analyst Yatin Suneja maintained Regeneron Pharmaceuticals with a Buy and … analyst Matthew Harrison maintained Regeneron Pharmaceuticals with an Overweight rating …
-
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2025 Earnings Call Transcript
02 Aug 2025 12:35 GMT
… ;A Session
Follow Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Follow Regeneron Pharmaceuticals Inc. (NASDAQ:REGN … now disconnect.
Follow Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Follow Regeneron Pharmaceuticals Inc. (NASDAQ:REGN …
-
Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
01 Aug 2025 09:34 GMT
Regeneron Pharmaceuticals, Inc. REGN will release earnings … in the year-ago period. Regeneron Pharmaceuticals projects to report quarterly revenue … four prior lines of therapy.
Regeneron Pharmaceuticals shares fell 1.6% to …
-
Exploring Regeneron Pharmaceuticals's Earnings Expectations
31 Jul 2025 14:12 GMT
… on Regeneron Pharmaceuticals.
Analysts have given Regeneron Pharmaceuticals a … Need to Know About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals discovers, develops, … Financial Story of Regeneron Pharmaceuticals
Market Capitalization Highlights: …
-
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market to Witness Growth at a CAGR of ~6% by 2032 | DelveInsight
05 Aug 2025 17:00 GMT
… , Inc., GlaxoSmithKline, Verona Pharma plc, Regeneron Pharmaceuticals, Sanofi, MedImmune LLC, EpiEndo Pharmaceuticals …
-
Diabetes Associated Ophthalmic Treatment Market Report 2025-2034: Rising to USD 69.09 Billion at a 6.90% CAGR
05 Aug 2025 12:42 GMT
… Inc.
Oxurion NV
Bayer AG
Regeneron Pharmaceuticals Inc.
Alcon Inc.
These companies …
-
FDA Issues CRL to Odronextamab in Pretreated Follicular Lymphoma
04 Aug 2025 20:59 GMT
… ;refractory follicular lymphoma. News release. Regeneron Pharmaceuticals, Inc. February 26, 2025. Accessed …
-
Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
04 Aug 2025 20:30 GMT
… a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic™ (linvoseltamab-gcpt), which … (linvoseltamab) [Package Insert]. Tarrytown, NY. Regeneron Pharmaceuticals. 2025. 2Bumma N, Richter J …
-
Uncovering Potential: Amgen's Earnings Preview
04 Aug 2025 14:47 GMT
… Sciences, Vertex Pharmaceuticals and Regeneron Pharmaceuticals, three prominent industry players, … an Outperform trajectory for Regeneron Pharmaceuticals, with an average … Sciences, Vertex Pharmaceuticals and Regeneron Pharmaceuticals are presented, shedding …
-
US open: Stocks higher, rebound from heavy losses
04 Aug 2025 14:51 GMT
… . (EA) $157.08 3.01%
Regeneron Pharmaceuticals Inc. (REGN) $558.87 2 …
About
© 1995-2025